We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Optimizing the Treatment Continuum With a Molecular-Based Approach in HER2+ GI Cancers
July 18, 2024
12:00 PM - 01:00 PM EDT
Josep Tabernero, MD, PhD
Sara Lonardi, MD
Zev A. Wainberg, MD
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
September 05, 2024
John H. Stone, MD, MPH
Yoh Zen, MD, PhD, FRCPath
Avinash Kambadakone-Ramesh, MD, DNB, FRCR
J. Matthias Löhr, MD
An FDA-Approved Therapeutic Treatment Option for Polymyalgia Rheumatica
Priya Reddy, MD
Ara Dikranian, MD
KOL KNOCKOUT™: Endocrinology Edition – Thyroid Titans Clash to Enhance Outcomes in Thyroid Eye Disease – Round 3
Malini Gupta, MD, ECNU, FACE
Kaniksha Desai, MD, ECNU, FACE
Sonalika Khachikian, MD
John Woody Sistrunk, MD
The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Patients?
Jennifer Caudle, DO
Thomas C. Wright, Jr., MD
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
Patricia A. Mangan, RN, MSN, APRN-BC
KOL KNOCKOUT™: Endocrinology Edition – Thyroid Titans Clash to Enhance Outcomes in Thyroid Eye Disease – Round 2
Rokshana R. Thanadar, MD, FACE, FEAA
Melissa Garduno Young, MD, FACE, FACP, ECNU
Addressing Patient Management in ASCVD Risk Reduction: A Collaborative Approach
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Charles P. Vega, MD
KOL Knockout™: Endocrinology Edition – Thyroid Titans Clash to Enhance Outcomes in Thyroid Eye Disease Round 1
Alireza Falahati, MD, FACE
Anupam Kotwal, MD, MSc, FACE, FRCP (Edin)
New Frontiers in Optimizing Patient Outcomes in Multiple Sclerosis: Strategies for Early Intervention to Address Progression Independent of Relapse
Stephen Krieger, MD
Tirisham Gyang, MD
Augusto Miravalle, MD, FAAN
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education